Citation Impact
Citing Papers
A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses
2003
Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist
2004 StandoutNobel
A small-molecule switch for Golgi sulfotransferases
2004 StandoutNobel
Inositol pyrophosphates promote tumor growth and metastasis by antagonizing liver kinase B1
2015
Contrasting Properties of Hypoxia-Inducible Factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-Associated Renal Cell Carcinoma
2005 StandoutNobel
The Hypoxia-Inducible Factor 2α N-Terminal and C-Terminal Transactivation Domains Cooperate To Promote Renal Tumorigenesis In Vivo
2007 StandoutNobel
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
The F-box protein TIR1 is an auxin receptor
2005 StandoutNature
Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway
2004
Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex
2004
MYC on the Path to Cancer
2012 Standout
Understanding protein non-folding
2010
Quality control of plant peroxisomes in organ specific manner via autophagy
2014 StandoutNobel
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
2007 StandoutNature
Chemical genetics: tailoring tools for cell biology
2003
Catalytic Three‐Component Ugi Reaction
2008 StandoutNobel
Small-Molecule Inhibition of c-MYC:MAX Leucine Zipper Formation Is Revealed by Ion Mobility Mass Spectrometry
2012 StandoutNobel
Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
2015
Reactive oxygen species and antioxidant machinery in abiotic stress tolerance in crop plants
2010 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Transcription factors as targets for cancer therapy
2002
Structural Rationale for the Coupled Binding and Unfolding of the c-Myc Oncoprotein by Small Molecules
2008
Modulation of Protein–Protein Interactions with Small Organic Molecules
2003
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways
2005 StandoutNobel
Cancer stem cells revisited
2017 Standout
Chemoimmunotherapy: reengineering tumor immunity
2013
Distribution and Characterization of Peroxisomes in Arabidopsis by Visualization with GFP: Dynamic Morphology and Actin-Dependent Movement
2002
Pyrrolidinyl‐Spirooxindole Natural Products as Inspirations for the Development of Potential Therapeutic Agents
2007 Standout
Targeted therapies in bladder cancer: an overview of in vivo research
2015
The Ubiquitin Ligase HectH9 Regulates Transcriptional Activation by Myc and Is Essential for Tumor Cell Proliferation
2005
Phosphorylation by Casein Kinase I Promotes the Turnover of the Mdm2 Oncoprotein via the SCFβ-TRCP Ubiquitin Ligase
2010 StandoutNobel
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
2017 StandoutNobel
Structure and regulation of the isocitrate lyase gene ICL1 from the yeast Saccharomyces cerevisiae
1993
The SCF ubiquitin ligase: insights into a molecular machine
2004
Strategies to Inhibit Myc and Their Clinical Applicability
2017
Wnt/β-Catenin Signaling and Disease
2012 Standout
Plant pathogens and integrated defence responses to infection
2001 StandoutNature
Bladder cancer
2016 Standout
A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia
2006
Advancing chemistry and biology through diversity-oriented synthesis of natural product-like libraries
2005
Targeting of proteins into the peroxisomal matrix
1992
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
2007 Standout
The Impact of Small Molecule Binding on the Energy Landscape of the Intrinsically Disordered Protein C-Myc
2012
Selective activation of apoptosis by a novel set of 4-aryl-3-(3-aryl-1-oxo-2-propenyl)-2(1H)-quinolinones through a Myc-dependent pathway
2008
NMR structure of a complex between MDM2 and a small molecule inhibitor
2004
Cancer therapeutics: Targeting the dark side of Myc
2005
Molecular regulation of vessel maturation
2003 Standout
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
Small-molecule perturbation of competing interactions between c-Myc and Max
2008
How Chemoproteomics Can Enable Drug Discovery and Development
2012
NMR solution structure of the pathogenesis-related protein P14a
1997 StandoutNobel
Diversity-oriented synthesis: exploring the intersections between chemistry and biology
2005
The STATs of cancer — new molecular targets come of age
2004 Standout
The von Hippel–Lindau protein, HIF hydroxylation, and oxygen sensing
2005 StandoutNobel
Therapeutic Targeting of Myc
2010
Intrinsically disordered proteins are potential drug targets
2010
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
2015
New developments for antibody-drug conjugate-based therapeutic approaches
2016
Id family of helix-loop-helix proteins in cancer
2005
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
In Vitro Cytotoxicity and In Vivo Efficacy, Pharmacokinetics, and Metabolism of 10074-G5, a Novel Small-Molecule Inhibitor of c-Myc/Max Dimerization
2010
Small Molecule Modulators of Transcription
2006
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
2013 Standout
Evolutionary families of peptidases
1993
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Immunotherapy for the Treatment of Urothelial Carcinoma
2016
Chemical Genetics
2006
Seed Storage Oil Mobilization
2008
Physiology meets biophysics: Visualizing the interaction of hypoxia-inducible factor 1α with p300 and CBP
2002 StandoutNobel
Targeting MYC-Regulated miRNAs to Combat Cancer
2010
Ramshackle (Brwd3) promotes light-induced ubiquitylation of Drosophila Cryptochrome by DDB1-CUL4-ROC1 E3 ligase complex
2013 StandoutNobel
Functional information and the emergence of biocomplexity
2007 StandoutNobel
Bladder Cancer
2020 Standout
Exploring the Metabolic and Genetic Control of Gene Expression on a Genomic Scale
1997 StandoutScience
Discovery of an Inhibitor of a Transcription Factor Using Small Molecule Microarrays and Diversity-Oriented Synthesis
2003
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Highly Oxidized Peroxisomes Are Selectively Degraded via Autophagy in Arabidopsis
2013 StandoutNobel
Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity
2004
Classification of Intrinsically Disordered Regions and Proteins
2014 Standout
Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1
2007 StandoutNobel
Multiple Independent Binding Sites for Small-Molecule Inhibitors on the Oncoprotein c-Myc
2009
Visualization of Myc/Max/Mad Family Dimers and the Competition for Dimerization in Living Cells
2004
Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1α Degradation
2017 StandoutNobel
Differential expression of catalase genes in Nicotiana plumbaginifolia (L.).
1994
Active Oxygen Species in the Induction of Plant Systemic Acquired Resistance by Salicylic Acid
1993 StandoutScience
Kleine Moleküle als Transkriptionsmodulatoren
2006
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
2021 Standout
Identification of Pex13p a peroxisomal membrane receptor for the PTS1 recognition factor.
1996 StandoutNobel
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Increased tolerance to two oomycete pathogens in transgenic tobacco expressing pathogenesis-related protein 1a.
1993
Metastatic Prostate Cancer
2018
Discovery of Novel Myc−Max Heterodimer Disruptors with a Three-Dimensional Pharmacophore Model
2009
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Get a ligand, get a life: integrins, signaling and cell survival
2002
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
A Central Role of Salicylic Acid in Plant Disease Resistance
1994 StandoutScience
Oncolytic Viruses in Cancer Treatment
2016
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
Requirement of Salicylic Acid for the Induction of Systemic Acquired Resistance
1993 Science
Chemical Glycoproteomics
2016 StandoutNobel
Generation of Anti-trypanosomal Agents through Concise Synthesis and Structural Diversification of Sesquiterpene Analogues
2011 StandoutNobel
Works of Daniel Maslyar being referenced
Spatial patterns of gene expression in Brassica napus seedlings: identification of a cortex-specific gene and localization of mRNAs encoding isocitrate lyase and a polypeptide homologous to proteinases.
1989
The growth-promoting activity of the Bad protein in chicken embryo fibroblasts requires binding to protein 14-3-3
2001
Oncogenic transformation by β-catenin: deletion analysis and characterization of selected target genes
2002
Novel and useful properties of a chimeric plant promoter combining CaMV 35S and MAS elements
1990
Abstract LB-290: Targeting MUC16 with the antibody-drug conjugate (ADC) DMUC5754A in patients with platinum-resistant ovarian cancer: A phase I study of safety and pharmacokinetics.
2013
A First in Human Phase 1 Study of CG0070, a GM-CSF Expressing Oncolytic Adenovirus, for the Treatment of Nonmuscle Invasive Bladder Cancer
2012
630. A Phase 2 Randomized Study of GM-CSF Gene-Modified Autologous Tumor Cell Immunotherapy (CG8123) with and without Low- Dose Cyclophosphamide in Advanced Stage Non- Small Cell Lung Cancer (NSCLC)
2006
Phase II study of NKTR-102 in women with platinum-resistant/refractory ovarian cancer.
2010
A phase I study of DSTP3086S, an antibody-drug conjugate (ADC) targeting STEAP-1, in patients (pts) with metastatic castration-resistant prostate cancer (CRPC).
2014
A phase I study of DNIB0600A, an antibody-drug conjugate (ADC) targeting NaPi2b, in patients (pts) with non-small cell lung cancer (NSCLC) or platinum-resistant ovarian cancer (OC).
2014
PTEN loss as a predictive biomarker for the Akt inhibitor ipatasertib combined with abiraterone acetate in patients with metastatic castration-resistant prostate cancer (mCRPC)
2016
Coordinate expression of transcriptionally regulated isocitrate lyase and malate synthase genes in Brassica napus L.
1989
Granulocyte-macrophage colony-stimulating factor (GM-CSF)–secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML)
2009
Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts
2002